Temporary Use of Ordinary Prescriptions for Dangerous Drugs
The Dangerous Drugs Board (DDB) has temporarily authorized the use of ordinary prescriptions to prescribe dangerous drugs. This decision aims to improve access to essential medical treatments amid pressing global health challenges.
In a recent announcement, the DDB revealed that Board Regulation No. 10, Series of 2025, now permits licensed physicians to use standard triplicate prescription forms for dangerous drugs. This regulation will be effective until June 30, 2026, unless otherwise revoked.
Expanded Access Amid Health Emergencies
The move responds to the growing health threats posed by the resurgence of Covid-19, the spread of Mpox (formerly monkeypox), and an alarming rise in HIV infections nationwide. The regulation allows doctors holding a valid S2 license to issue ordinary prescriptions instead of the usual Department of Health (DOH) special (yellow) forms.
Under this rule, prescriptions must be issued in triplicate and contain only one dangerous drug or one preparation containing such drugs. Physicians may prescribe a supply that lasts up to 30 days, with exceptions for chronic conditions like epilepsy and dystonia, where a 60-day supply is allowed.
Empowering Healthcare Providers
DDB chairperson Secretary Oscar Valenzuela emphasized the regulation’s goal of broadening medical access, especially in underserved areas. “By easing prescription requirements for essential medications, we empower healthcare providers to deliver timely and essential treatments, especially in underserved communities,” Valenzuela commented.
The board also highlighted that this initiative aligns with the World Health Organization’s recommendations under the International Health Regulations, which advocate for improved access to regulated medicines during global health emergencies.
Addressing the HIV Surge and Legal Warnings
This regulation also responds to alarming data from the DOH, which recorded a 500 percent increase in HIV cases, with 5,101 new diagnoses from January to March of this year alone.
The DDB reminded medical practitioners that issuing unnecessary prescriptions will carry criminal liability under Section 18 of Republic Act No. 9165, the Comprehensive Dangerous Drugs Act of 2022. Likewise, unauthorized individuals who issue prescriptions claiming to be for dangerous drugs may face penalties under Section 19 of the same law.
For more news and updates on dangerous drugs and health regulations, visit Filipinokami.com.